Provided by Tiger Trade Technology Pte. Ltd.

Merck

147.76
-0.5900-0.40%
Pre-market: 148.050.2900+0.20%06:04 EDT
Volume:11.13M
Turnover:1.64B
Market Cap:364.55B
PE:116.09
High:148.69
Open:147.00
Low:145.95
Close:148.35
52wk High:156.92
52wk Low:77.58
Shares:2.47B
Float Shares:2.47B
Volume Ratio:1.03
T/O Rate:0.45%
Dividend:3.32
Dividend Rate:2.25%
EPS(TTM):1.27
EPS(LYR):7.28
ROE:6.96%
ROA:11.87%
PB:8.69
PE(LYR):20.30

Loading ...

Exclusive-u.s. Lawmaker Letters Request Documents on Hundreds of Trials over About 10 Years, Including on Data Protection Processes

THOMSON REUTERS
·
Jun 30

Scotiabank Raises Merck Price Target to $155 From $136, Sector Outperform Rating Kept

MT Newswires Live
·
Jun 30

Merck price target raised to $155 from $136 at Scotiabank

TIPRANKS
·
Jun 30

Merck Agrees With ADAP Crisis Task Force to Provide Access to HIV Treatment Idvynso

MT Newswires Live
·
Jun 29

Merck Says FDA Approves Once-daily HIV Combo Pill Idvynso

Reuters
·
Jun 29

Merck Announces New Agreement with Adap Crisis Task Force to Improve Access and Care for People Living with Hiv

THOMSON REUTERS
·
Jun 29

Weekly Winners | Bio-Techne Soars 23%; AbbVie Surges 17%; United Airlines Jumps 15%; Corning, Merck Gain 13%

Tiger Newspress
·
Jun 28

Health Care Roundup: Market Talk

Dow Jones
·
Jun 27

Merck & Co. Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jun 27

US Starts Vaccine Effort for Ebola Bundibugyo as Outbreak Spreads

Reuters
·
Jun 27

Merck (MRK) Stock After 64% One-Year Rally And Terns Deal Is It Priced Fairly?

Simply Wall St.
·
Jun 26

Qualcomm, Merck, Rockwell Automation And A Real Estate Stock On CNBC’s ‘Final Trades’

Benzinga
·
Jun 26

UBS Remains a Buy on Merck KGaA (0O14)

TIPRANKS
·
Jun 26

Barclays Sticks to Their Buy Rating for Merck & Company (MRK)

TIPRANKS
·
Jun 26

Barclays Reaffirms Their Hold Rating on Merck KGaA (0O14)

TIPRANKS
·
Jun 26

PRESS Digest-financial Times - June 26

Reuters
·
Jun 26

Movement Alert|Merck Rises 3.08% in Regular Trading, Keytruda Plus Trodelvy Wins FDA Approval for Triple-Negative Breast Cancer

Market Focus
·
Jun 26

The Dow Hits Record High, Caterpillar Surges Over 5%

Tiger Newspress
·
Jun 25

Bio-Techne Surges as Merck Agrees to Acquire Company at $73 Per Share in Cash

Market Focus
·
Jun 25

Merck Gains FDA Approval for Keytruda Plus Trodelvy in PD-L1 Positive Breast Cancer

MT Newswires Live
·
Jun 25